A–Z Medicines Dataset of India

This dataset provides comprehensive structured records of medicines marketed in India, including drug name, brand name, generic composition, dosage strength, formulation type, manufacturer, and price information. The dataset has been processed through a systematic exploratory data analysis workflow to ensure consistency and analytical usability. Duplicate entries were removed, medicine names and compositions were standardized, pricing fields were range-validated, and categorical attributes such as dosage form were normalized. Outlier detection was applied to pricing values to eliminate unrealistic entries. The final dataset is exported in a clean, analytics-ready format compatible with machine learning models, healthcare dashboards, and pharmaceutical market analysis tools.

Data Quality

The dataset is organized in a structured tabular format with consistent column naming and standardized data types. All duplicate records have been removed and key pharmaceutical attributes such as composition and manufacturer have been normalized to prevent ambiguity. Numeric pricing values have undergone statistical validation to eliminate negative or unrealistic values. Categorical fields such as dosage form and brand classification have been cleaned and standardized. The dataset is ready for analytical workflows and supports pricing analysis, clustering, and predictive modeling.

Use Cases

This dataset can be used for pharmaceutical pricing analysis, medicine market intelligence, supply chain optimization, and healthcare cost modeling. Researchers can analyze pricing patterns across manufacturers and dosage types. Pharmaceutical companies can use it for competitive benchmarking and portfolio optimization. It also supports machine learning applications such as price prediction, drug category classification, and clustering of medicines based on composition and usage patterns. The dataset is suitable for healthcare analytics dashboards and academic research in pharmaceutical economics.

Limitations

The dataset is community-sourced and may not represent official regulatory databases. Pricing information reflects available records at the time of compilation and may not include real-time market updates. It does not include clinical trial data, patient-level prescription data, or regulatory approval timelines. The dataset should be used for analytical and research purposes and not for direct medical or prescribing decisions.

Methodology

The dataset was prepared using a structured data cleaning and validation framework. The workflow included schema normalization, duplicate removal, missing value assessment, categorical standardization of drug names and formulations, and pricing validation through statistical range checks. Outlier detection was applied to identify unrealistic price entries. Manufacturer names were normalized to maintain consistency. The final dataset was exported in UTF-8 encoded CSV format, ensuring compatibility with Python, R, SQL, and business intelligence platforms for pharmaceutical analytics and modeling.